Data / Form D filings / WiTii Pharmaceuticals, Inc.
WiTii Pharmaceuticals, Inc.: Form D filing
WiTii Pharmaceuticals, Inc., a pharmaceuticals company in Denver, CO, filed a Form D with the SEC in 2024. The latest, on July 11, 2024, reports $125,000 sold of a $500,000 offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1499 W. 120TH AVENUE, SUITE 110, Denver, CO, 80234
- Phone
- (720) 469-0635
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Not Applicable
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2029215
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 11, 2024 | New notice | $500,000 | $125,000 | $375,000 | 2 | Jun 21, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Anand Shukla | Executive Officer, Director, Promoter | |
| Sreejayan Nair | Director |
Every Form D from the week of Jul 8, 2024 · All recent filings in Colorado · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what WiTii Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.